Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patients

• Asıl Yazarlar: Zufit Hexner-Erlichman (Yazar), Maria Veiga- (Yazar), Yoav Zehavi (Yazar), Zahava Vadasz (Yazar), Adi D. Sabag (Yazar), Sameh Tatour (Yazar), Ronen Spiegel (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

BackgroundGlycogen storage disease type 1b (GSD1b) is an ultra-rare autosomal recessive disorder, caused by mutations in SLC37A4 gene. Affected patients present with episodes of fasting hypoglycemia and lactic acidosis, hepatomegaly, growth retardation, hyperlipidemia and renal impairment. In additi...